Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Engelhardt

Showing results (221-230 of 255) with videos related to

Pageof 26
Sort By:
Haematologica|January 29, 2016
Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantationBrian G Engelhardt, Sophie Paczesny, Dae Kwang Jung, et al.
Cancers|July 9, 2022
Prediction Models and Decision Aids for Women with Ductal Carcinoma In Situ: A Systematic Literature ReviewRenée S J M Schmitz, Erica A Wilthagen, Frederieke van Duijnhoven, et al.
Teratogenesis, Carcinogenesis, and Mutagenesis|January 1, 1983
Criteria for the standardization of Salmonella mutagenicity tests: results of a collaborative study. II. Studies to investigate the effect of bacterial liquid culture preparation conditions on Salmonella mutagenicity test resultsB A Herbold, P Arni, A Driesel, et al.
Leukemia & Lymphoma|September 6, 2007
High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomesBrian G Engelhardt, Derek W Holland, Stephen J Brandt, et al.
Cancers|August 27, 2021
Preferences of Treatment Strategies among Women with Low-Risk DCIS and OncologistsDanalyn Byng, Valesca P Retèl, Ellen G Engelhardt, et al.
Breast (Edinburgh, Scotland)|July 6, 2024
DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCISE G Engelhardt, R S J M Schmitz, M A Gerritsma, et al.
Frontiers in Oncology|July 30, 2019
Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different <i>in vivo</i> Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center ExperienceVipul Sheth, Vanessa Kennedy, Hugues de Lavallade, et al.
The Lancet. Oncology|May 20, 2014
Validity of Adjuvant! Online program in older patients with breast cancer: a population-based studyNienke A de Glas, Willemien van de Water, Ellen G Engelhardt, et al.
American Journal of Hematology|May 12, 2020
The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemiaMichael Byrne, Nathalie Danielson, Salyka Sengsayadeth, et al.
Frontiers in Immunology|September 11, 2023
Vaccine-induced neutralizing antibody responses to seasonal influenza virus H1N1 strains are not enhanced during subsequent pandemic H1N1 infectionPetra Mooij, Daniella Mortier, Aafke Aartse, et al.
Pageof 26

Showing results (221-230 of 255) with videos related to

Sort By:
Pageof 26
Haematologica|January 29, 2016
Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantationBrian G Engelhardt, Sophie Paczesny, Dae Kwang Jung, et al.
Cancers|July 9, 2022
Prediction Models and Decision Aids for Women with Ductal Carcinoma In Situ: A Systematic Literature ReviewRenée S J M Schmitz, Erica A Wilthagen, Frederieke van Duijnhoven, et al.
Teratogenesis, Carcinogenesis, and Mutagenesis|January 1, 1983
Criteria for the standardization of Salmonella mutagenicity tests: results of a collaborative study. II. Studies to investigate the effect of bacterial liquid culture preparation conditions on Salmonella mutagenicity test resultsB A Herbold, P Arni, A Driesel, et al.
Leukemia & Lymphoma|September 6, 2007
High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomesBrian G Engelhardt, Derek W Holland, Stephen J Brandt, et al.
Cancers|August 27, 2021
Preferences of Treatment Strategies among Women with Low-Risk DCIS and OncologistsDanalyn Byng, Valesca P Retèl, Ellen G Engelhardt, et al.
Breast (Edinburgh, Scotland)|July 6, 2024
DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCISE G Engelhardt, R S J M Schmitz, M A Gerritsma, et al.
Frontiers in Oncology|July 30, 2019
Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different <i>in vivo</i> Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center ExperienceVipul Sheth, Vanessa Kennedy, Hugues de Lavallade, et al.
The Lancet. Oncology|May 20, 2014
Validity of Adjuvant! Online program in older patients with breast cancer: a population-based studyNienke A de Glas, Willemien van de Water, Ellen G Engelhardt, et al.
American Journal of Hematology|May 12, 2020
The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemiaMichael Byrne, Nathalie Danielson, Salyka Sengsayadeth, et al.
Frontiers in Immunology|September 11, 2023
Vaccine-induced neutralizing antibody responses to seasonal influenza virus H1N1 strains are not enhanced during subsequent pandemic H1N1 infectionPetra Mooij, Daniella Mortier, Aafke Aartse, et al.
Pageof 26